FDA Investigator Ramesh Potla, PhD
Ramesh Potla, PhD has inspections in 5 countries as of 30 Oct 2023. Ramesh Potla, PhD has collaborated with a combined 2360 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
30 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
Japan,
United States of America,
Switzerland,
China
Co-Investigator(s):
Adaliz Santaliz Cruz,
Alan A Rivera,
Anastasia G Lolas,
Andrea George, PhD,
Ann Marie Montemurro,
Arlene M Badillo,
Ashley N Queen, PhD,
Bo Chi, PhD,
Brandon C Heitmeier,
Brian D Nicholson,
Calvin B Koerner,
Carl A Anderson,
Charles I Ann,
Charles M Edwards,
Chen Sun, PhD,
Chikako Torgioe,
Christopher D Leach,
Christopher Downey, PhD,
Christopher T Middendorf,
Colleen Thomas, PhD,
Cynthia Jim, CSO,
Dennis Cantellops Paite,
Diane L Raccasi,
Donald C Obenhuber, PhD,
Dov Pluznik, PhD,
Dr. Jun Liu, PhD,
Eliezar Ramos,
Erika V Butler,
Francis A Guidry,
Gwyn G Dickinson,
Helen B Ricalde,
Ivis L Negron,
Ivis Lnegron Torres,
Jacek Cieslak, PhD,
Jennifer Lalama,
Jerri Baker,
Jonathan W Chapman,
Jorge L Lajara,
Jose A Cruz,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose R Lopez,
Jose Velez,
Julie D Bringger,
Justin A Boyd,
Katherine E Jacobitz,
Kathleen R Jones, PhD,
Kent C Faul,
Kevin A Gonzalez,
Kevin D Kallander,
Kham Phommachanh,
Kim Lthomas Cruse,
Larry K Austin,
Laurimer Kuilan Torres,
Libia M Lugo,
Linda Thai,
Lindsey S Fleischman,
LT Rafael Gonzalez,
Madushini Dharmasena, PhD,
Maria G Gutierrez Hoffman,
Maria Gutierrez Hoffman, PhD,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Marie F Morin,
Marion Michaelis,
Maxwell Van Tassell, PhD,
Mekonnen Lemma Dechassa, PhD,
Mekonnon Lemmadechassa,
Merry Christie, PhD,
Michael A Charles,
Michael Shanks, MS,
Michelle Y Clark Stuart,
Milva E Melendez,
Milva Emelendez Perales,
Minh D Phan,
Muna Algharibeh,
Myriam M Sosa,
Nibin Varghese, MS,
Nicholas Obiri, PhD,
Nikolay Spiridonov,
Noreen Muniz,
Noreen Muñiz,
Nydia E Colon,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Paul Z Balcer,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebecca E Dombrowski,
Rebecca Parrilla,
Rebecca Rodriguez,
Riley C Myers, PhD,
Robert C Coleman,
Robert Darius,
Robert J Martin,
Rong Wang, PhD,
Scott R Nichols, PhD,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Stephen D Brown,
Steven C Madzo,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Susan M Jackson,
Thomas E Friel,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy Wadkin, PhD,
Tracy Denison, PhD,
Vaishali J Patel,
Vilmary Negron Rodriguez,
Wendy G Tan, PhD,
Yanming An, PhD,
Yasamin Ameri,
Zachary L Stamm,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Ramesh Potla, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2017 | FDA 483 | WuXi Biologics Co., Ltd. - Form 483, 2017-08-02 |
August, 2019 | FDA 483 | Novartis Pharma AG - Form 483, 2019-08-29 |
April, 2019 | EIR | WuXi Biologics Co., Ltd. - EIR, 2019-04-16 |
December, 2017 | FDA 483 | Kyowa Kirin Co., Ltd. - Form 483, 2017-12-21 |
March, 2014 | FDA 483 | Amgen Manufacturing Ltd - Form 483, 2014-03-29 |
March, 2019 | EIR | Kashiv BioSciences, LLC - EIR, 2019-03-12 |
March, 2016 | FDA 483 | Astellas Pharma Inc. - Form 483, 2016-03-18 |
March, 2019 | FDA 483 | Kashiv BioSciences, LLC - Form 483, 2019-03-12 |
August, 2018 | FDA 483 | Porton Biopharma Limited - Form 483, 2018-08-01 |
January, 2017 | EIR | AbbVie Biotechnology LTD - EIR, 2017-01-13 |
April, 2019 | FDA 483 | WuXi Biologics Co., Ltd. - Form 483, 2019-04-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more